No results for ‘’
Cipla Ltd
₹1472.30
(0.06%)
Tue, 04 Aug 2026, 02:29 am
Health Technology
Pharmaceuticals: Other
24.5KCipla Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 32.67 | 27.38 | 24.36 | 22.15 | 24.61 | 26.06 | 21.37 | 19.74 | 22.22 | 48.51 | 30.33 | 47.38 | 31.04 | 27.95 | 22.07 | 27.37 | 32.68 | 25.96 | 29.30 | 22.10 |
| Price to book ratio | 10.01 | 5.66 | 4.55 | 3.93 | 4.58 | 3.87 | 3.20 | 3.38 | 3.07 | 5.29 | 3.57 | 3.80 | 3.07 | 2.84 | 2.16 | 3.59 | 3.94 | 3.11 | 4.52 | 3.73 |
| Price to sales ratio | 6.87 | 5.32 | 4.26 | 3.44 | 4.97 | 4.20 | 3.56 | 3.76 | 3.15 | 5.23 | 3.07 | 3.35 | 2.92 | 2.64 | 2.03 | 3.45 | 3.79 | 3.20 | 4.70 | 4.24 |
| Price to cash flow ratio | 73.61 | 51.18 | 45.70 | 47.15 | 25.45 | 25.05 | 14.11 | 20.90 | 20.47 | 55.20 | 25.97 | 21.35 | 31.77 | 26.61 | 11.55 | 17.80 | 24.94 | 22.13 | 28.23 | 22.28 |
| Enterprise value | 20274Cr | 18281Cr | 17582Cr | 17889Cr | 26579Cr | 26265Cr | 23410Cr | 29194Cr | 31660Cr | 58223Cr | 45352Cr | 50760Cr | 46137Cr | 44605Cr | 35502Cr | 64327Cr | 78922Cr | 67571Cr | 114000Cr | 106000Cr |
| Enterprise value to EBITDA ratio | 33.72 | 26.41 | 27.67 | 18.56 | 23.52 | 22.97 | 14.74 | 14.22 | 17.15 | 32.93 | 18.14 | 21.21 | 16.92 | 14.94 | 11.80 | 15.30 | 17.14 | 13.31 | 17.85 | 14.93 |
| Debt to equity ratio | 0.24 | 0.04 | 0.15 | 0.22 | 0 | 0.09 | 0 | 0.11 | 0.12 | 0.16 | 0.45 | 0.33 | 0.29 | 0.29 | 0.20 | 0.11 | 0.05 | 0.03 | 0.02 | 0.01 |
| Return on equity % | 34.36 | 25.60 | 20.05 | 19.03 | 21.11 | 15.74 | 16 | 18.55 | 14.56 | 11.33 | 12.19 | 8.37 | 10.54 | 10.45 | 10.05 | 14.11 | 12.85 | 12.66 | 16.45 | 18.21 |
Cipla Ltd Enterprise Value
The Cipla Ltd Enterprise Value is a key financial metric used by investors to evaluate Cipla Ltd's valuation, profitability, and overall financial performance. Tracking the Cipla Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Cipla Ltd (NSE: CIPLA, BSE: 500087) is currently trading at ₹1472.30, with a market capitalization of ₹118991.57Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Cipla Ltd Enterprise Value is essential for fundamental analysis.
Cipla Ltd Enterprise Value Current Value
The current Cipla Ltd Enterprise Value stands at 106000Cr.
The Cipla Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Cipla Ltd Enterprise Value Historical Trend
The Cipla Ltd Enterprise Value has shown the following historical trend:
- 2024: 106000Cr
- 2023: 114000Cr
- 2022: 67571Cr
- 2021: 78922Cr
- 2020: 64327Cr
The decline in Cipla Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Cipla Ltd Enterprise Value Indicates for Investors
The Cipla Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Cipla Ltd.
Cipla Ltd Enterprise Value Analysis Summary
The Cipla Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Cipla Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Cipla Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.